Article
Licensed
Unlicensed
Requires Authentication
Relationship of the CAG repeat polymorphism of the MEF2A gene and coronary artery disease in a Chinese population
-
Yaling Han
Published/Copyright:
July 8, 2007
Abstract
Background: Recently, a mutation in the human myocyte enhancer factor-2A (MEF2A) gene was reported to be responsible for an autosomal dominant form of coronary artery disease (CAD). In addition, missense mutations in sporadic CAD patients were also described. Both results support the disease-causing relationship between MEF2A and CAD/myocardial infarction. On the other hand, conflicting hypotheses have been put forward in other studies.
Methods: We screened exons 7 and 11 of MEF2A through single-stranded conformation polymorphism PCR and direct sequencing to clarify the relationship between MEF2A and CAD in an independent case-control study involving 726 individuals in China.
Results: Exon 11 showed a high degree of heterogeneity, which was caused by a polyglutamine (CAG)n polymorphism. Frequencies for the different (CAG)n alleles were not the same between patient and control groups. Of note, the distribution frequency of the (CAG)9 allele was higher in the patient group than in the control group (p<0.001). This effect was independent of age, gender, hypertension, diabetes mellitus, hyperlipidemia and smoking in a logistic regression model (p=0.001, odds ratio 1.245, 95% CI 1.095–1.417). It was also observed that the (CAG)9 allele was related to the extent of CAD, which was defined as no CAD, or single-, double- or triple-vessel disease (p trend 0.000).
Conclusions: Based on our data, we speculate that the CAG repeat polymorphism is associated with coronary heart disease in the Chinese population and the (CAG)9 allele may be an independent predictive factor for CAD.
Clin Chem Lab Med 2007;45:987–92.
Received: 2007-2-8
Accepted: 2007-3-26
Published Online: 2007-07-08
Published in Print: 2007-08-01
©2007 by Walter de Gruyter Berlin New York
You are currently not able to access this content.
You are currently not able to access this content.
Articles in the same Issue
- Congress of Clinical Chemistry and Laboratory Medicine, Joint Annual Congress of The Austrian Society for Laboratory Medicine and Clinical Chemistry (OEGLMKC) and the The German United Society of Clinical Chemistry and Laboratory Medicine (DGKL), Vienna, Austria, September 19-22, 2007
- Interpretation of laboratory results: the Reference Intervals, a necessary evil?
- Implementation of haemoglobin A1c results traceable to the IFCC reference system: the way forward
- Exhaled breath condensate: a new method for lung disease diagnosis
- Biochemical markers of alcoholism
- Polymorphisms of the peroxisome proliferator-activated receptor-γ coactivator-1α gene are associated with hypertrophic cardiomyopathy and not with hypertension hypertrophy
- Association of interleukin-1 genetic polymorphisms with the risk of rheumatoid arthritis in Chinese population
- Highest accuracy of combined consensus clinical criteria and SNRPN gene molecular markers in diagnosis of Prader-Willi syndrome in Thai patients
- Use of maternal plasma for non-invasive prenatal diagnosis of fetal ABO genotypes
- Relationship of the CAG repeat polymorphism of the MEF2A gene and coronary artery disease in a Chinese population
- Specific real-time PCR vs. fluorescent dyes for serum free DNA quantification
- Increased glycation of hemoglobin and plasma proteins in normotensive, non-diabetic obese Indian subjects: putative role of lipid peroxides
- The relationship between red blood cell and reticulocyte indices and serum markers of iron status in the cord blood of newborns
- Association of amino-terminal propeptide of type III procollagen and acute myocardial rejection in male patients receiving heart transplantation
- Changes in platelet count and indices in pulmonary tuberculosis
- Activity or mass concentration of bone-specific alkaline phosphatase as a marker of bone formation
- A simple isocratic HPLC assay to determine linezolid concentrations in different biomatrices for in vivo and in vitro studies
- Pitfalls in measuring the endocannabinoid 2-arachidonoyl glycerol in biological samples
- Partitioning reference values for several subpopulations using cluster analysis
- A plea for intra-laboratory reference limits. Part 1. General considerations and concepts for determination
- A plea for intra-laboratory reference limits. Part 2. A bimodal retrospective concept for determining reference limits from intra-laboratory databases demonstrated by catalytic activity concentrations of enzymes
- Biological variation of thyroid autoantibodies and thyroglobulin
- Monitoring glycaemic control: is there evidence for appropriate use of routine measurement of glycated haemoglobin?
- Performance and utility of a cost-effective collagen-binding assay for the laboratory diagnosis of Von Willebrand disease
- Hook effect in calcitonin immunoradiometric assay
- Rapid genotyping of the Ser447Stop variant of the lipoprotein lipase gene using real-time fluorescent PCR
- Global standardization of glycated hemoglobin measurement: the position of the IFCC Working Group
- Recommendation for term and measurement unit for “HbA1c”
- Desirable performance standards for HbA1c analysis – precision, accuracy and standardisation Consensus statement of the Australasian Association of Clinical Biochemists (AACB), the Australian Diabetes Society (ADS), the Royal College of Pathologists of Australasia (RCPA), Endocrine Society of Australia (ESA), and the Australian Diabetes Educators Association (ADEA)
- IFCC Position Paper: Report of the IFCC Taskforce on Ethics: Introduction and framework
- IFCC Awards: Call for Nominations
- Call for papers, ideas and initiatives
Keywords for this article
CAG repeat;
coronary artery diseases;
myocyte enhancer factor-2A (MEF2A);
polymorphism
Articles in the same Issue
- Congress of Clinical Chemistry and Laboratory Medicine, Joint Annual Congress of The Austrian Society for Laboratory Medicine and Clinical Chemistry (OEGLMKC) and the The German United Society of Clinical Chemistry and Laboratory Medicine (DGKL), Vienna, Austria, September 19-22, 2007
- Interpretation of laboratory results: the Reference Intervals, a necessary evil?
- Implementation of haemoglobin A1c results traceable to the IFCC reference system: the way forward
- Exhaled breath condensate: a new method for lung disease diagnosis
- Biochemical markers of alcoholism
- Polymorphisms of the peroxisome proliferator-activated receptor-γ coactivator-1α gene are associated with hypertrophic cardiomyopathy and not with hypertension hypertrophy
- Association of interleukin-1 genetic polymorphisms with the risk of rheumatoid arthritis in Chinese population
- Highest accuracy of combined consensus clinical criteria and SNRPN gene molecular markers in diagnosis of Prader-Willi syndrome in Thai patients
- Use of maternal plasma for non-invasive prenatal diagnosis of fetal ABO genotypes
- Relationship of the CAG repeat polymorphism of the MEF2A gene and coronary artery disease in a Chinese population
- Specific real-time PCR vs. fluorescent dyes for serum free DNA quantification
- Increased glycation of hemoglobin and plasma proteins in normotensive, non-diabetic obese Indian subjects: putative role of lipid peroxides
- The relationship between red blood cell and reticulocyte indices and serum markers of iron status in the cord blood of newborns
- Association of amino-terminal propeptide of type III procollagen and acute myocardial rejection in male patients receiving heart transplantation
- Changes in platelet count and indices in pulmonary tuberculosis
- Activity or mass concentration of bone-specific alkaline phosphatase as a marker of bone formation
- A simple isocratic HPLC assay to determine linezolid concentrations in different biomatrices for in vivo and in vitro studies
- Pitfalls in measuring the endocannabinoid 2-arachidonoyl glycerol in biological samples
- Partitioning reference values for several subpopulations using cluster analysis
- A plea for intra-laboratory reference limits. Part 1. General considerations and concepts for determination
- A plea for intra-laboratory reference limits. Part 2. A bimodal retrospective concept for determining reference limits from intra-laboratory databases demonstrated by catalytic activity concentrations of enzymes
- Biological variation of thyroid autoantibodies and thyroglobulin
- Monitoring glycaemic control: is there evidence for appropriate use of routine measurement of glycated haemoglobin?
- Performance and utility of a cost-effective collagen-binding assay for the laboratory diagnosis of Von Willebrand disease
- Hook effect in calcitonin immunoradiometric assay
- Rapid genotyping of the Ser447Stop variant of the lipoprotein lipase gene using real-time fluorescent PCR
- Global standardization of glycated hemoglobin measurement: the position of the IFCC Working Group
- Recommendation for term and measurement unit for “HbA1c”
- Desirable performance standards for HbA1c analysis – precision, accuracy and standardisation Consensus statement of the Australasian Association of Clinical Biochemists (AACB), the Australian Diabetes Society (ADS), the Royal College of Pathologists of Australasia (RCPA), Endocrine Society of Australia (ESA), and the Australian Diabetes Educators Association (ADEA)
- IFCC Position Paper: Report of the IFCC Taskforce on Ethics: Introduction and framework
- IFCC Awards: Call for Nominations
- Call for papers, ideas and initiatives
